New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
07:06 EDTMDCOThe Medicines Co. downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded The Medicines Co. following the surprisingly negative cangrelor FDA panel. The firm said the setback removes and important value driver and now sees limited outperformance for shares. Price target lowered to $35 from $45.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
07:05 EDTMDCOThe Medicines Co. reports Q2 adjusted EPS 31c, may not compare to consensus (2c)
Reports Q2 revenue $183.8M, consensus $183.75M. Reports Q2 unadjusted net loss of (8c).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use